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A B S T R A C T
Pregnancy complications such as preeclampsia cause increased fetal oxidative stress and fetal growth restriction,
and associate with a higher incidence of adult metabolic syndrome. However, the pathophysiological con-
tribution of oxidative stress per se is experimentally difficult to discern and has not been investigated. This study
determined, if increased intrauterine oxidative stress (IUOx) affects adiposity, glucose and cholesterol meta-
bolism in adult Ldlr−/−xSod2+/+ offspring from crossing male Ldlr−/−xSod2+/+ mice with Ldlr−/
−xSod2 +/- dams (IUOx) or Ldlr−/−xSod2 +/- males with Ldlr−/−xSod2+/+ dams (control). At 12 weeks
of age mice received Western diet for an additional 12 weeks. Adult male IUOx offspring displayed lower body
weight and reduced adiposity associated with improved glucose tolerance compared to controls. Reduced weight
gain in IUOx was conceivably due to increased energy dissipation in white adipose tissue conveyed by higher
expression of Ucp1 and an accompanying decrease in DNA methylation in the Ucp1 enhancer region. Female
offspring did not show comparable phenotypes. These results demonstrate that fetal oxidative stress protects
against the obesogenic effects of Western diet in adulthood by programming energy dissipation in white adipose
tissue at the level of Ucp1.
1. Introduction
Epidemiological evidence indicates that stressful environmental
conditions during sensitive periods of early development predispose to
chronic disease later in life [1]. Preeclampsia and intrauterine growth
restriction (IUGR) are particular manifestations of fetal stress associated
with a higher incidence of visceral obesity [2], hypertension and heart
disease [1] in adulthood. A common denominator of these adverse
perinatal conditions is intrauterine oxidative stress (IUOx) [3]. Oxida-
tive stress could thereby be a mere accompanying feature or the driving
force for metabolic programming. Increased levels of reactive oxygen
species (ROS) mechanistically contribute to atherosclerotic plaque
formation [4] and pancreatic β-cell dysfunction [5]. However, the in-
volvement of oxidative stress in fetal programming of the metabolic
syndrome has not been investigated. Since IUOx often co-manifests
with IUGR, defining the role of oxidative stress per se is challenging. To
address the specific impact of segregated IUOx on metabolic syndrome
components in adulthood we devised a genetic mouse model where
IUOx is not associated with either IUGR, maternal obesity or diabetes.
Specifically, we used Mn2+-superoxide dismutase (Sod2) deficient
mice, in which oxidative stress is significantly increased even in a
heterozygous state [6]. Our results demonstrate that, independent of
fetal weight, increased IUOx in utero epigenetically programs protection
against diet-induced adiposity, insulin resistance and hyperlipidemia in
Sod2-wild-type male offspring of Sod2-deficient mothers. Conceivably,
this protection is mediated by increased energy expenditure due to
browning of WAT as indicated by higher Ucp1 expression concomitant
with reduced methylation of its enhancer.
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2. Materials and methods
2.1. Animal experiments
Mice heterozygous for Sod2tm1Leb and homozygous for Ldlrtm1Her
(#006883, Jackson Laboratories, Bar Harbor, USA) were crossed with
Ldlr-knockouts (#002207). Thus, all studied mice are homozygous
Ldlr-knockouts (−/−). IUOx are Sod2 (+/+) offspring originating
from mating Sod2 (+/-) females with Sod2 (+/+) males. Controls
originated from Sod2 (+/+) females mated with Sod2 (+/-) males.
Animals were co-housed in temperature-controlled conditions with
12:12 h light/dark cycles with ad libitum access to AIN93G semisyn-
thetic diet (#D10012G, Research Diets, USA). At 12 weeks of age ex-
perimental animals received Western diet containing 60% fat and
0.25% cholesterol (#D14010701, Research Diets). Complete diet
composition is provided in Supplementary Table 2. Supplementary
Fig. 3 summarizes the timeline of the study.
2.2. Body composition analysis
Body composition measurements were performed by dual energy x-
ray absorptiometry (pDEXA, Norland-Stratec, Norland Medical Systems
Inc., UK). During the procedure the animals were anesthetized with
isoflurane for a total of 15min. Fat and lean body mass were calculated
based on the automated bone mass density evaluation.
2.3. Fat balance
The fat absorption efficiency was determined as the difference be-
tween dietary intake of long chain fatty acids and their amount re-
covered from feces. Fatty acids were methylated and extracted from
food and fecal samples as previously described [7] followed by gas
chromatography analysis. The free fatty acid concentrations of the
species 14:0 to 26:0 per gram of sample were calculated relative to a
17:0-internal standard.
2.4. Glucose tolerance test and insulin measurement
Following a 12 h overnight fast mice were injected i.p. with 1.25 g/
kg D-glucose and blood glucose was measured before and 15, 30, 60 and
120min after the injection using OneTouch Ultra glucose strips
(12%CV, Life Scan, USA). Fifteen minutes after the glucose injection
plasma samples were collected for determination of circulating insulin
levels (Ultrasensitive Insulin ELISA Kit, Crystal Chem, USA). HOMA-IR
was calculated as described [8].
2.5. Plasma lipids and lipoprotein profiles
Blood was collected via retro-orbital bleeding under isoflurane an-
esthesia. Samples were centrifuged at 500×g, 4C° for 10min. Total
cholesterol and triglycerides were measured with colorimetric kits
(13%CV #11489232 and 14.5%CV #11877771, Roche, Germany).
Pooled plasma samples (n= 4–5/group) were loaded onto a Superose
6 H R 10/300 GL column (GE Healthcare, UK) for lipoprotein separation
via fast protein liquid chromatography (FPLC) as described [9].
2.6. Fecal neutral sterols and bile acids
Feces were dried, weight and ground. Neutral sterol and bile salt
profiles were determined exactly as previously described [10]. Fol-
lowing petroleum ether extraction neutral sterols were measured in the
organic phase by gas chromatography. Total bile acids were determined
by gas chromatography in the aqueous phase after concentration with
SepPak® C18 cartridges (Waters, USA).
2.7. Isoprostane determination
Samples underwent extraction by use of a C18 cartridge and then
were purified by thin-layer chromatography. Next, 8-isoPGF2alpha le-
vels were assayed by a specific and sensitive sandwich ELISA method,
as previously described [11].
2.8. RT-qPCR
RNA was isolated from frozen tissues using Trizol® (Thermo Fischer
Scientific, USA) and quantified with a NanoDrop 2000 (Thermo Fischer
Scientific). cDNA synthesis and real-time PCR quantification of gene
expression levels were performed as previously detailed [10].
2.9. ELISA
In plasma, levels of SAA (MyBioSource, San Diego, CA,
MBS2500351) and of the proinflammatory cyto- and chemokines (all R
&D Systems, Minneapolis, MN) Il-6 (M6000B), Tnf-α (MTA00B), Il-1β
(MLB00C) and Ccl2 (MJE00B) were determined following the manu-
facturer's instructions.
2.10. DNA methylation analysis
DNA methylation analysis was performed as described (24). Briefly,
genomic DNA from WAT (170 ng) was bisulfite-converted with the EZ
DNA Methylation-Gold kit (Zymo Research, USA). Bisulfite-specific
primers were designed with the PyroMark Assay Design software for
CpG positions located in the Ucp1 enhancer and promoter
(Supplementary Table 1). The methylation status was analyzed by
pyrosequencing (PyroMarkQ24, Qiagen). PyroMarkQ24 software was
used to determine the methylation percentage of individual CpG posi-
tions.
2.11. Statistical analysis
Statistical analysis was performed using Graph Pad Prism 6.0. Data
are presented as median and interquartile range. Differences between
groups were calculated using Mann-Whitney or Kruskal-Wallis followed
by post-hoc Tukey, or repeated measures ANOVA followed by Fischer's
exact test. P-values ≤ 0.05 were considered statistically significant.
2.12. Study approval
All animal experiments comply with the ARRIVE guidelines and
were approved by the IACUC at the University of Groningen with
permit DEC6493AB.
3. Results
3.1. Maternal Sod2-heterozygosity causes fetal oxidative stress but not
IUGR
Full ablation of SOD2 is lethal, and heterozygosity results in IUGR
[12]. However, here we focused exclusively on SOD2-wild-type off-
spring, where fetal weight (E18.5) was not different between pups
originating from SOD2+/− dams versus SOD2+/+ dams (Fig. 1A &
Supplementary Fig. 1A). Hence, in our model adult phenotypes occur
independent of IUGR. Levels of the oxidative stress marker isoprostane
8-isoPGF2α were significantly higher in IUOx pups (Fig. 1B &
Supplementary Fig. 1B) demonstrating that indeed maternal SOD het-
erozygosity causes increased oxidative stress exposure in utero in both
sexes. The increase in isoprostanes in female IUOx pups was lower than
in males, likely due to a higher oxidative stress buffering capacity of the
female placenta, since mRNA expression of SOD1 (1.00 ± 0.08 vs.
0.76 ± 0.05, p < 0.05) and catalase (1.00 ± 0.05 vs. 0.84 ± 0.04,
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p < 0.05) was higher in female compared with male IUOx placentas.
3.2. IUOx exposure results in reduced body weight gain and glucose
tolerance in adult male offspring
At 12 weeks of age SOD2-wild-type offspring were subjected to a
Western diet challenge. Although body weight of IUOx and controls
were identical at the start of the diet, from week 6 onwards IUOx mice
gained significantly less weight during the whole experiment (Fig. 1C).
Notably, this effect was observed only in male offspring while females
had comparable weight gain (Supplementary Fig. 1C). Lower body
weight associates with better glucose tolerance [13]. However, already
before starting the Western diet, at 12 weeks of age when body weights
did not differ, IUOx-males showed a trend towards improved glucose
tolerance (Fig. 1D) compared to controls in intraperitoneal glucose
tolerance tests. After 12 weeks on Western diet both groups had become
more glucose intolerant (Fig. 1E) than prior to the challenge. However,
IUOx-males were still more glucose tolerant than controls (Fig. 1D–E).
Circulating insulin was also lower (p < 0.05) in IUOx-mice (Fig. 1F,
left) resulting in a decreased HOMA-IR (p < 0.05, Fig. 1F, right). Fe-
males did not show such differences in glucose tolerance
(Supplementary Fig. 1D).
When IUOx males were continued on a chow diet until 24 weeks of
age, blood glucose, insulin and HOMA-IR were not different compared
to controls (data not shown). Hepatic expression of the acute phase
protein SAA was also comparable between groups as were plasma levels
of SAA and Ccl2; Il-6, Il-1β and Tnf-α were not detectable in plasma of
either IUOx or control offspring (data not shown).
3.3. IUOx results in lower plasma cholesterol in adult male offspring
LDLR-knockout mice develop diet-induced hyperlipidemia [14]. At
24 weeks of age, IUOx males had 22% lower fasting total plasma cho-
lesterol compared to controls (p < 0.05, Fig. 2A), and lower plasma TG
(p= 0.075, Fig. 2B). This reduction was mostly due to lower choles-
terol within Apo-B containing lipoproteins (Fig. 2C). Next, we in-
vestigated fecal sterol excretion. While cholesterol recovered from feces
was comparable between groups (Fig. 2D), fecal bile acid output was
higher in IUOx mice (Fig. 2E) suggesting an overall improved choles-
terol excretion. Such effects on plasma lipids and fecal sterol excretion
were absent in female offspring (Supplementary Figs. 1E–F).
Fig. 1. IUOx protects against diet-induced obesity and insulin resistance in adulthood. A) Embryonic weight of male Ldlr −/− Sod2 + / + offspring at 18.5
days. N > 12/group. B) Oxidative stress marker 8-isoPGF2α in plasma of male Ldlr −/− Sod2 + / + offspring at 18.5 days (n = 6/group). Data are given as
median and interquartile range. Mann-Whitney U test. C) Body weight trajectories from the start of Western diet feeding until 24 weeks of age. D) Glucose tolerance
test in 12 week old offspring fed chow diet. E) Glucose tolerance test at 24 weeks, after 12 weeks on Western diet. Repeated measures ANOVA posthoc Fischer's exact
test. F) Glucose-induced insulin secretion after 12 weeks of Western diet and HOMA-IR after 12 weeks on WD. Data are given as median and interquartile range;
males, n=4–5/group. Mann-Whitney U test. *p < 0.05, **p < 0.01.
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3.4. Male IUOx offspring display reduced adiposity due to browning of
white adipose tissue
Body composition analysis at 24 weeks revealed a markedly reduced
adipose tissue mass in IUOx males (Fig. 3A); lean body mass was not
different (data not shown). Decreased adiposity could be explained by
either lower caloric intake, decreased absorption or increased energy
expenditure. Caloric intake (Fig. 3B) and fat absorption (Fig. 3C) were
comparable. As surrogate parameters for energy expenditure, we
measured mRNA expression levels of genes associated with increased
energy dissipation in brown (BAT) and white adipose tissue (WAT).
Ucp1 is a key mediator of increased energy expenditure [15]. Usually
expressed in BAT in a Pparg co-activator 1a (Pgc1a)-dependent manner,
its upregulation in WAT, the so-called ‘browning’, decreases obesity
[16]. We observed a marked 3-fold induction of Ucp1 mRNA (p=0.05)
in WAT of IUOx males (Fig. 3D), while Ucp1 expression in BAT did not
change. This observation lends strong support to a causative contribu-
tion of the higher Ucp1 expression in WAT of male IUOx mice to the
improved metabolic state in this group. In female offspring expression
levels of Ucp1 were comparable between controls and IUOx consistent
with the lack of differential weight gain (Supplementary Fig. 1G). The
lack of differential expression of Ucp1 in female offspring, where a
long-term metabolic impact of intrauterine oxidative stress was
missing, supports a critical role for Ucp1 in conveying the protective
effects of IUOx.
3.5. Pgc1a-independent mechanisms determine increased Ucp1 expression
in adulthood following intrauterine oxidative stress exposure
Ucp1 upregulation in WAT was previously described in Pparg
knockout mice resistant to diet-induced obesity [17]. However, ex-
pression of both Pparg and its model target gene Cd36, responsible for
fatty acid uptake, were comparable between IUOx and control mice in
different tissues (Supplementary Fig. 2A), indicating that likely Pparg is
not causally involved in Ucp1 regulation in our model. The expression
levels of Ucp1 can also be modulated by reactive oxygen species [18].
We hence measured the expression of key genes involved in regulating
oxidative metabolism, such as Pgc1a, which mediates Ucp1-dependent
adaptive thermogenesis in BAT [19]. However, Pgc1a expression was
identical between IUOx and control males (Supplementary Fig. 2B)
suggesting another, likely epigenetic, mechanism to underlie the reg-
ulation of Ucp1 expression in response to IUOx.
3.6. Differential methylation at the Ucp1 enhancer region associates with
altered UCP-1 expression in white adipose tissue
Earlier work identified several CpG positions in the Ucp1 gene en-
hancer and promoter region [20]. To test whether these (Fig. 3E) are
sensitive to IUOx, we analyzed them in WAT of IUOx and controls.
While the Ucp1 promoter was not differentially methylated
(Supplementary Fig. 2C), CpG2 in the enhancer region was significantly
less methylated specifically in male IUOx mice (Fig. 3F). Similar effects
in Ucp1 expression or gene methylation were absent in female IUOx
compared with control offspring (Supplementary Fig. 1H).
Combined these data suggest that IUOx exposure results in differ-
ential methylation at the Ucp1 locus in a sexually dimorphic fashion.
These epigenetic changes confer protection against the adverse meta-
bolic effects of Western diet in male offspring via browning of WAT.
4. Discussion
Although clinically and epidemiologically relevant, it is difficult in a
human system to determine effects of intrauterine oxidative stress ex-
posure on the offspring, since oxidative stress is almost inevitably
mixed with other conditions such as IUGR that by themselves impact
programming of metabolic disease [1]. In contrast, the mouse model
described in this study allowed us to investigate the specific impact of
IUOx on metabolic phenotypes in adult life. Combined, our data suggest
that IUOx exposure results in differential methylation at the Ucp1 locus
in a sexually dimorphic fashion. These epigenetic changes confer pro-
tection against the adverse metabolic effects of Western diet in male
offspring via browning of WAT.
How can a supposedly adverse factor such as increased ROS confer
protection against diet-induced metabolic dysfunction? In general,
obesogenic diets and increased adiposity are associated with higher
levels of systemic oxidative stress. Moderate levels of ROS, however,
also fulfill an important physiological role in regulating gene expression
and cell signaling pathways governing e.g. fetal development and vas-
cularization [21]. Also, relevant beneficial effects of exercise are largely
conveyed by increased oxidative stress which mitigates insulin re-
sistance by altering the expression of ROS-sensitive transcriptional
regulators of glucose homeostasis such as Pparg and Pgc1a [22]. From
these and similar observations the concept of “mitohormesis” devel-
oped [23]. It suggests that exposure to small doses of a stressor such as
ROS, can protect against larger subsequent doses. In our model, in-
creased intrauterine ROS exposure appears to condition metabolic
networks towards an improved response to an increasing oxidative and
nutritional burden associated with the Western diet in adulthood. While
Fig. 2. IUOx protects against the effects of Western diet on cholesterol
metabolism. A) Total plasma cholesterol levels and B) plasma triglycerides at
24 weeks of age. Data are given as median and interquartile range; n= 4–5/
group, Mann-Whitney U test. C) Cholesterol distribution over the different li-
poprotein fractions following FPLC separation of pooled plasma samples of at
least 4 mice/group at the age of 24 weeks. D) Fecal neutral sterol and E) total
fecal bile acid excretion at 24 weeks of age. Data are presented as median and
interquartile range, n=4–5/group, Mann-Whitney U test, *p < 0.05.,
**p < 0.01.
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we are not aware of comparable studies in a mammalian system, work
in Drosophila indicated that increased oxidative stress due to hy-
perbaric pressure in early development resulted in increased resistance
to oxidative stress in adult flies and an extended lifespan [24]. Hy-
perbaric oxygen chambers are in use as treatment for severe IUGR due
to placental insufficiency [25]. This improves short-term outcomes,
however, long-term metabolic effects have not been systematically
addressed.
One relatively frequent finding of metabolic programming studies is
the sex-specificity of the offspring's phenotype. Embryonic sex can
modulate placental size, function and ability to respond to adverse
stimuli [26]; hence sex-specific placental differences are proposed to
contribute to the sexual dimorphism in programming. Recently several
gender-specific placental differences in response to oxidative stress
were shown in the guinea pig [27]. The difference we observed in
isoprostane levels between male and female fetuses in the IUOx group
potentially relates to the anthropomorphic and physiological changes
between the genders in adult age and is, based on the lower expression
of catalase and Sod1, likely conveyed by a decreased placental anti-
oxidative defense in males.
In summary, our data demonstrate that intrauterine oxidative stress
exposure results in resistance to diet-induced adiposity, glucose intol-
erance and dyslipidemia in adult mice. This response is restricted to
male offspring. Mechanistically, this protective effect is conveyed by
programming of energy dissipation in WAT via increased expression of
Ucp1, at least partly mediated by decreased DNA methylation in its
enhancer region. These data might have important implications also for
interpreting the effects of oxidative stress during pregnancy on
programming of metabolic disease in humans.
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Fig. 3. IUOx reduces body fat content by increasing energy dissipation via epigenetic upregulation of Ucp1 in WAT. A) Body fat quantification via pDEXA at
24 weeks of age, after 12 weeks of Western diet feeding. B) Food intake based on averaged values over 3 consecutive days. C) Long-chain fatty acid absorption. D)
Ucp1 mRNA expression levels in white and brown adipose tissue. E) Schematic of the CpG dinucleotides localization in the Ucp1 enhancer and promoter regions. F)
DNA methylation state of individual CpG pairs located in the enhancer region of Ucp1. Data are presented as median and interquartile range, n=4–5/group, Mann-
Whitney U test, *p < 0.05.
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